NCT ID | NCT02154776 |
Title | Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer. (LeeBLet) |
Recruitment | Completed |
Gender | female |
Phase | Phase I |
Variant Requirements | yes |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult |